Articles by Jill Wechsler - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jill Wechsler

Food and Drug Safety Crises Prompt White House, Congressional Action

The FDA is poised to gain more authority and resources to ensure product quality.
Apr 1, 2009

The FDA is poised to gain more authority and resources to ensure product quality.

Biotech Therapies Face Disclosure Requirements

Broader transparency in product prices and payments to researchers aim to curb conflicts of interest and rationalize drug expenditures.
Mar 1, 2009

Broader transparency in product prices and payments to researchers aim to curb conflicts of interest and rationalize drug expenditures.

Congress Approves Down Payment on Health Reform

Feb 27, 2009

In addition to providing tax breaks and investing billions to jump start the economy, last month?s economic stimulus package supports healthcare for the unemployed and takes steps to modernize the nation?s troubled healthcare system.

Biotech Drug Prices Under Scrutiny

Efforts to cut spending on healthcare will focus on outlays for prescription drugs by Medicare and other health programs.
Feb 1, 2009

With cuts in healthcare, biotech drugs are under scrutiny.

Revitalization, Reform Ahead for The FDA

FDA aims to regain public confidence in 2009.
Jan 1, 2009

FDA aims to regain public confidence in 2009.

Daschle to Spearhead Health Reform Efforts

Dec 10, 2008

Although no official announcement has been made, former Senate majority leader Tom Daschle is most likely slated to head the Obama administration’s efforts to enact health reform legislation as the new secretary of the Department of Health and Human Services.

Waxman to Head Hey House Committee

Dec 10, 2008

In the Obama administration, an important ally in the House for Tom Daschle, who is expected to be named secretary of the Department of Health and Human Services, will be Rep. Henry Waxman (D-CA), who unseated John Dingell (D-MI), the long-time top Democrat on the House Energy and Commerce Committee, to become the panel’s new chairman.

Big Changes Ahead for Biotech Manufacturers

To expand coverage amidst the economic crisis, Obama will be looking hard for ways to cut healthcare costs.
Dec 1, 2008

To expand coverage amidst the economic crisis, Obama will be looking hard for ways to cut healthcare costs.

Nanotechnology Creates Opportunities, Challenges for Biotech Manufacturers

Policy makers weigh new rules to ensure the safety and quality of nanomaterials in biomedical products.
Nov 1, 2008

The FDA and other regulatory authorities are evaluating new regulations to ensure the safety and quality of nanomaterials in biomedical products.

ADVERTISEMENT

ADVERTISEMENT

Click here